Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy
Phase 4
Terminated
- Conditions
- Glaucoma
- Interventions
- Drug: Travoprost/Timolol Maleate BAK-Free Fixed Combination
- First Posted Date
- 2012-01-23
- Last Posted Date
- 2014-12-03
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 37
- Registration Number
- NCT01514721
- Locations
- 🇧🇷
Alcon Investigational Site, Sao Paulo, Brazil
Clinical Investigation of AcrySof® IQ ReSTOR® +2.5 D Multifocal Intraocular Lens (IOL) Model SN6AD2 [SV25T0]
Not Applicable
Completed
- Conditions
- Cataracts
- Interventions
- Device: AcrySof® IQ ReSTOR® +2.5 D Multifocal IOL Model SN6AD2 [SV25T0]Device: AcrySof® IQ Monofocal IOL Model SN60WF
- First Posted Date
- 2012-01-16
- Last Posted Date
- 2015-05-27
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 409
- Registration Number
- NCT01510717
Efficacy of Changing to TRAVATAN® From Prior Therapy
Phase 4
Completed
- Conditions
- Open-angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2012-01-13
- Last Posted Date
- 2014-06-13
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 191
- Registration Number
- NCT01510145
Travacom Post Marketing Surveillance Study
Phase 4
Withdrawn
- Conditions
- Open-angle GlaucomaOcular Hypertension
- Interventions
- Drug: Travoprost/timolol fixed combination (Travacom)
- First Posted Date
- 2012-01-13
- Last Posted Date
- 2012-10-18
- Lead Sponsor
- Alcon Research
- Registration Number
- NCT01510132
Long Term Safety Protocol for the AcrySof CACHET Phakic Lens
Not Applicable
Completed
- Conditions
- Myopia
- Interventions
- Device: ACRYSOF CACHET Phakic Lens (L-series)
- First Posted Date
- 2011-12-22
- Last Posted Date
- 2019-07-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 657
- Registration Number
- NCT01497067
- Locations
- 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Performance Evaluation of DAILIES® TOTAL1™ in First Time Contact Lens Wearers
Not Applicable
Completed
- Conditions
- Myopia
- Interventions
- Device: Delefilcon A contact lens
- First Posted Date
- 2011-12-19
- Last Posted Date
- 2013-07-19
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 102
- Registration Number
- NCT01494545
Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues
Not Applicable
Completed
- Conditions
- Contact Lens Care
- Interventions
- Device: Hydrogen peroxide-based contact lens care systemDevice: PHMB-containing contact lens solutionDevice: Soft contact lenses
- First Posted Date
- 2011-12-19
- Last Posted Date
- 2013-09-27
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 79
- Registration Number
- NCT01494818
Efficacy of Changing to TRAVATAN® From Prior Therapy
Phase 4
Completed
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2011-12-16
- Last Posted Date
- 2014-05-19
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 202
- Registration Number
- NCT01493427
A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN 0.004% Ophthalmic Solution
Terminated
- Conditions
- Open-angle Glaucoma
- Interventions
- Procedure: Trabecular Meshwork Tissue Collection
- First Posted Date
- 2011-12-06
- Last Posted Date
- 2013-05-14
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 88
- Registration Number
- NCT01485822
Lens Wearing Experience and Biocompatibility of a Marketed Multi-Purpose Disinfecting Solution in Silicone Hydrogel and Soft Contact Lens Wearers
Not Applicable
Completed
- Conditions
- Refractive Error
- Interventions
- Device: OPTI-FREE PureMoist
- First Posted Date
- 2011-12-05
- Last Posted Date
- 2012-10-10
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 175
- Registration Number
- NCT01484938
- Locations
- 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath